T1	Participants 55 91	patients with post-stroke depression
T2	Participants 383 451	patients with DSM-IV post-stroke major depressive-like episode (PSD)
T3	Participants 461 508	Fifty inpatients with first-ever stroke and PSD
T4	Participants 574 691	Twenty-five were treated with the SNRI venlafaxine SR (75-150 mg/die), and 25 with the SSRI fluoxetine (20-40 mg/die)
